A new blood test developed at Stanford Medicine has shown to accurately diagnose invasive mold disease in most cases, replacing invasive procedures. The test detects genetic material from mold in the bloodstream, allowing for faster diagnosis and treatment, which has been linked to improved patient outcomes.
Researchers have identified a novel therapeutic pathway for treating keloid scars by targeting the enzyme CYP24A1 and vitamin D. The study found that inhibiting CYP24A1 can reduce profibrotic gene expression, offering a fresh perspective on keloid treatment strategies.
Researchers at Stanford Medicine classified breast cancers into three main groups based on structural variations in their DNA, including repeats of oncogenes and small DNA circles. Understanding these variations could aid physicians in making decisions and point to new targeted therapeutic interventions.
A new buried interface engineering strategy has been proposed to stabilize zinc anodes in aqueous zinc-ion batteries. The approach involves embedding a zincophilic Sn layer within a corrosion-resistant ZnS layer, which accelerates zinc deposition and shields the anode from corrosion.
Hydrogen and carbon monoxide adsorb onto platinum atoms in nanoscale voids, with hydrogen diffusing faster due to smaller size. The team's findings highlight the importance of engineering voids for next-generation sensors and gas separation.
Researchers identified peri-centrosome-localized siRNAs in C. elegans, which accumulate at the centrosome during cell cycle and are essential for development. The study provides new insights into RNAi-mediated gene regulation in C. elegans.
A Stanford Medicine study found that AI-powered chatbots can effectively answer nuanced clinical questions and improve physician performance. The research showed that chatbots outperformed doctors in certain scenarios, particularly when combined with human expertise, suggesting a potential future direction for AI-assisted medical decis...
Groundbreaking progress in TB vaccine development and therapeutic innovations offer hope to curb the disease's devastating impact, with multi-antigen vaccines and mRNA-based platforms showing promise.